Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Line of Credit Outstanding

Line of Credit Outstanding at other companies

Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$3.05M-51.6%
Biote Corp. logo
Biote Corp.BTMD
$5M—

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:LinesOfCreditCurrent.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's line of credit outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's line of credit outstanding?
USANA Health Sciences (USNA) reported line of credit outstanding of $14M in Q1 2026.
How has USANA Health Sciences's line of credit outstanding changed year-over-year?
USANA Health Sciences's line of credit outstanding decreased by 39.1% year-over-year, from $23M to $14M.
What does line of credit outstanding mean?
This metric represents the total principal amount currently drawn and unpaid under a company's revolving credit facility or similar short-term debt arrangements. It serves as a key indicator of a company's reliance on external financing to manage working capital requirements and short-term liquidity needs. Monitoring this balance helps investors assess the company's financial flexibility and its ability to meet immediate obligations without relying solely on operating cash flow.